The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: a double blind randomized controlled trial

Table 3 Anthropometry changes in patients treated with placebo and L-carnitine before and after 12 weeks of treatment

		L-carnitine group (n = 34)	P^a	Placebo group (n = 36)	P^b	P^c
Weight (Kg)	before	78.7 ± 10.86	0.001	78.91 ± 12.18	0.001	0.937
	after	75.19 ± 10.84		76.99 ± 12.70		0.527
	chnge	−2.76 ± 1.69		−1.95 ± 1.73		0.052
BMI (kg/m2)	before	33.04 ± 6.67	0.001	32.10 ± 4.30	0.001	0.471
	after	31.87 ± 6.56		31.29 ± 4.56		0.669
	change	−1.21 ± 0.84		−0.79 ± 0.70		0.027
Waist circumference (Cm)	before	105.13 ± 9.04	0.001	105.92 ± 10.57	0.001	0.728
	after	99.45 ± 11.72		102.39 ± 10.1		0.262
	change	−5.65 ± 5.85		−3.64 ± 3.37		0.081
Hip circumference (Cm)	before	115.63 ± 9.37	0.001	117.87 ± 10.56	0.001	0.332
	after	108.44 ± 9.67		112.19 ± 10.58		0.127
	change	−6.82 ± 3.56		−5.64 ± 4.07		0.201
Free fat mass (%)	before	24.00 ± 1.74	0.8	24.59 ± 2.64	0.531	0.253
	after	24.11 ± 1.75		23.99 ± 3.78		0.865
	change	0.04 ± 0.09		−0.71 ± 3.47		0.384
Fat mass (%)	before	45.19 ± 4.85	0.03	43.63 ± 6.77	0.915	0.251
	after	44.07 ± 4.33		43.95 ± 5.66		0.921
	change	−0.71 ± 1.83		−0.3 ± 1.93		0.360
Visceral fat (%)	before	10.71 ± 1.95	0.001	10.47 ± 1.82	0.644	0.587
	after	10.24 ± 2.104		10.50 ± 1.89		0.581
	change	−0.41 ± 0.49		−0.55 ± 0.752		0.320

Mean ± SD (all such values)
^aDetermined with the use of paired Student’s t tests for differences between baseline and follow-up in the L-carnitine group
^bDetermined with the use of paired Student’s t tests for differences between baseline and follow-up in the placebo group
^cDetermined with the use of independent samples t tests between L-carnitine and placebo groups

ISSN: 1471-2474